TP53 and non-small cell lung carcinoma: In the present study, we showed that both 5-dAzaC and TSA were able to reduce NSCLC cells proliferation in a p53-independent manner, as A549 cells possess a wild-type TP53 and both alleles of TP53 are deleted in Calu-1 cells.